Hosaka M - Search Results

1

Telomerase activity in primary prostate cancer.

Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Lin Y, et al. Among authors: hosaka m. J Urol. 1997 Mar;157(3):1161-5. J Urol. 1997. PMID: 9072562

2

Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.

Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y. Miyamoto H, et al. Among authors: hosaka m. J Urol. 1996 Apr;155(4):1444-7. J Urol. 1996. PMID: 8632608

3

[Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer].

Fujinami K, Kondo I, Miura T, Harada M, Uemura H, Hosaka M, Kawasaki C. Fujinami K, et al. Among authors: hosaka m. Hinyokika Kiyo. 1998 Apr;44(4):259-63. Hinyokika Kiyo. 1998. PMID: 9617622 Free article. Japanese.

4

Detection of telomerase activity in prostate needle-biopsy samples.

Lin Y, Uemura H, Fujinami K, Hosaka M, Iwasaki Y, Kitamura H, Harada M, Kubota Y. Lin Y, et al. Among authors: hosaka m. Prostate. 1998 Jul 1;36(2):121-8. doi: 10.1002/(sici)1097-0045(19980701)36:2<121::aid-pros7>3.0.co;2-l. Prostate. 1998. PMID: 9655264

5

Telomerase activity in human bladder cancer.

Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y. Lin Y, et al. Among authors: hosaka m. Clin Cancer Res. 1996 Jun;2(6):929-32. Clin Cancer Res. 1996. PMID: 9816252

6

The worst histologic elements predict prognosis in moderately-differentiated prostate cancer patients with androgen-withdrawal endocrine therapy.

Masuda M, Iki M, Noguchi S, Mikata K, Kubota Y, Harada M, Hosaka M. Masuda M, et al. Among authors: hosaka m. Eur Urol. 1999 Sep;36(3):197-202. doi: 10.1159/000067997. Eur Urol. 1999. PMID: 10450002

7

Telomerase activity in oral cancer.

Miyoshi Y, Tsukinoki K, Imaizumi T, Yamada Y, Ishizaki T, Watanabe Y, Sasakura Y, Lin Y, Hosaka M, Kubota Y. Miyoshi Y, et al. Among authors: hosaka m. Oral Oncol. 1999 May;35(3):283-9. doi: 10.1016/s1368-8375(98)00117-1. Oral Oncol. 1999. PMID: 10621849

8

Pathologic 'fused gland' as a prognostic factor for prostate cancer.

Noguchi S, Kubota Y, Kondoh I, Harada M, Masuda M, Uemura H, Hosaka M. Noguchi S, et al. Among authors: hosaka m. Urol Int. 2000;65(2):84-8. doi: 10.1159/000064845. Urol Int. 2000. PMID: 11025429

9

[Study of free to total prostate specific antigen ratio in the detection of patients with prostate cancer].

Ohuchi H, Mikata K, Miyoshi Y, Ohta J, Osada Y, Uemura H, Yao M, Takeda M, Noguchi S, Kubota Y, Hosaka M, Jinza S, Asakura T, Ebato T. Ohuchi H, et al. Among authors: hosaka m. Nihon Hinyokika Gakkai Zasshi. 2000 Dec;91(12):695-9. doi: 10.5980/jpnjurol1989.91.695. Nihon Hinyokika Gakkai Zasshi. 2000. PMID: 11201129 Free article. Japanese.

10

[A pathological study of incidental carcinoma of the prostate. Pathological study of age-groups].

Uemura H, Fujimoto K, Kawasaki C, Fujii H, Kinoshita Y, Hosaka M, Miura T, Kondo I, Harada M, Fukushima S, et al. Uemura H, et al. Among authors: hosaka m. Nihon Hinyokika Gakkai Zasshi. 1992 Jan;83(1):48-52. doi: 10.5980/jpnjurol1989.83.48. Nihon Hinyokika Gakkai Zasshi. 1992. PMID: 1564826 Free article. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

582 results

Search Page